What's killing us? For decades, global health leaders have focused on diseases that can spread - AIDS, tuberculosis, new flu bugs. They pushed for vaccines, better treatments and other ways to control germs that were only ...
Sep 14, 2011
0
0
Neuroblastoma is the most common cancer outside of the brain in infants and young children and often fails to respond to therapy. Though it can appear in several areas of the body, it commonly develops as a solid tumor most ...
Nov 8, 2019
0
2
A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy ...
Oct 5, 2011
0
0
A University of Colorado Cancer Center study being presented Saturday at the 2016 Genitourinary Cancers Symposium shows genetic differences between colorectal cancer (CRC) in young and old patients, possibly pointing toward ...
Jan 21, 2016
0
2
In a first-of-its-kind clinical trial, physician-scientists at University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine found that a new non-invasive technology ...
May 18, 2015
0
20
Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines—such as doxorubicin, frequently used against breast cancer—kill ...
Dec 27, 2022
0
74
New research indicates that there is a higher risk of early death among patients with oropharynx cancer when not caused by human papillomavirus (HPV), than those whose tumors are HPV-positive. The findings are published early ...
Jan 13, 2020
0
6
About 10 percent of lung cancers in the United States and as many as 40 percent in Asia are driven by mutations in the EGFR gene. EGFR targeted treatment advances over the previous decade now result in multiple options for ...
Jan 25, 2017
0
3
Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.
Dec 8, 2011
0
0
(HealthDay)—For patients with advanced pancreatic cancer receiving chemotherapy, the systemic inflammation response index (SIRI), based on peripheral neutrophil, monocyte, and lymphocyte counts, can predict survival, according ...
May 16, 2016
0
0
